| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |